ZH
Nuclear Energy
Nuclear Medicine
Nuclear Industry/Defense
Looking forward to it with great anticipation~
Nuclear Energy
Tumor-Targeting Boron Agents for Neutron Capture Therapy: A Key Active Pharmaceutical Ingredient for Next-Generation Cancer Therapy"
2024-10-12
In March 2020, the world’s first Boron Neutron Capture Therapy (BNCT) system, along with the first boron-based drug, Steboronine, received approval in Japan for the treatment of inoperable advanced or recurrent head and neck cancer.
Tumor-Targeting Boron Agents for Neutron Capture Therapy: A Key Active Pharmaceutical Ingredient for Next-Generation Cancer Therapy"
2024-08-31
In March 2020, the world’s first Boron Neutron Capture Therapy (BNCT) system, along with the first boron-based drug, Steboronine, received approval in Japan for the treatment of inoperable advanced or recurrent head and neck cancer.
Nuclear Medicine
Tumor-Targeting Boron Agents for Neutron Capture Therapy: A Key Active Pharmaceutical Ingredient for Next-Generation Cancer Therapy"
2024-10-12
In March 2020, the world’s first Boron Neutron Capture Therapy (BNCT) system, along with the first boron-based drug, Steboronine, received approval in Japan for the treatment of inoperable advanced or recurrent head and neck cancer.
Tumor-Targeting Boron Agents for Neutron Capture Therapy: A Key Active Pharmaceutical Ingredient for Next-Generation Cancer Therapy"
2024-08-31
In March 2020, the world’s first Boron Neutron Capture Therapy (BNCT) system, along with the first boron-based drug, Steboronine, received approval in Japan for the treatment of inoperable advanced or recurrent head and neck cancer.
Nuclear Industry/Defense
Looking forward to it with great anticipation~